HESTERBIO Q1 FY27 results at a glance
HESTER BIOSCIENCES LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹77.24 cr |
|---|
| Revenue YoY | -8.2% |
|---|
| Operating profit | ₹15.73 cr |
|---|
| Operating margin | 20.4% |
|---|
| Net profit | ₹96.98 cr |
|---|
| Net profit YoY | +489.8% |
|---|
| Net profit QoQ | +506.8% |
|---|
| Net margin | 125.6% |
|---|
| Basic EPS | ₹113.71 |
|---|
| TTM revenue | ₹326 cr |
|---|
| TTM net profit | ₹136 cr |
|---|
| TTM net margin | 41.8% |
|---|
HESTERBIO Q1 FY27 results: what the numbers say
HESTER BIOSCIENCES LTD (HESTERBIO) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹77.24 cr and a net profit of ₹96.98 cr, translating into earnings per share of ₹113.71.
Compared with the same quarter a year earlier, revenue declined by -8.2% and net profit grew sharply by +489.8%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹15.73 cr, an operating margin of 20.4% versus 22.2% a year ago — a contraction of 1.8 percentage points.
HESTERBIO quarter-wise results table
Revenue
₹77.24 cr
-8.2% YoY
Net profit
₹96.98 cr
+489.8% YoY
Operating profit
₹15.73 cr
-15.6% YoY
HESTER BIOSCIENCES LTD (HESTERBIO) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹77.24 cr | ₹15.73 cr | ₹96.98 cr | 20.4% | 125.6% | ₹113.71 | +489.8% | +506.8% |
| Q4 FY262026-03-31 | ₹100 cr | ₹28.42 cr | ₹15.98 cr | 28.4% | 16.0% | ₹19.45 | — | +82.3% |
| Q3 FY262025-12-31 | ₹77.42 cr | ₹13.36 cr | ₹8.77 cr | 17.3% | 11.3% | ₹10.94 | — | -39.3% |
| Q2 FY262025-09-30 | ₹70.97 cr | ₹7.36 cr | ₹14.45 cr | 10.4% | 20.4% | ₹16.85 | — | -12.1% |
| Q1 FY262025-06-30 | ₹84.11 cr | ₹18.63 cr | ₹16.44 cr | 22.2% | 19.5% | ₹20.33 | — | — |
| TTM (last 4 quarters) | ₹326 cr | ₹64.88 cr | ₹136 cr | 19.9% | 41.8% | ₹160.95 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
HESTERBIO quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
HESTER BIOSCIENCES LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹77.24 cr | ₹100 cr | ₹77.42 cr | ₹70.97 cr | ₹84.11 cr |
|---|
| Total expenses | ₹61.51 cr | ₹71.69 cr | ₹64.05 cr | ₹63.61 cr | ₹65.47 cr |
|---|
| Gross profit | ₹60.17 cr | ₹80.66 cr | ₹56.69 cr | ₹51.65 cr | ₹61.64 cr |
|---|
| Operating profit (EBIT) | ₹15.73 cr | ₹28.42 cr | ₹13.36 cr | ₹7.36 cr | ₹18.63 cr |
|---|
| Operating margin | 20.4% | 28.4% | 17.3% | 10.4% | 22.2% |
|---|
| Interest cost | ₹3.08 cr | ₹5.1 cr | ₹1.82 cr | ₹2.21 cr | ₹1.81 cr |
|---|
| Profit before tax | ₹16.33 cr | ₹25.09 cr | ₹13.52 cr | ₹17.04 cr | ₹20.19 cr |
|---|
| Tax expense | ₹4.95 cr | ₹8.54 cr | ₹4.21 cr | ₹2.71 cr | ₹2.89 cr |
|---|
| Effective tax rate | 30.3% | 34.0% | 31.2% | 15.9% | 14.3% |
|---|
| Net profit (PAT) | ₹96.98 cr | ₹15.98 cr | ₹8.77 cr | ₹14.45 cr | ₹16.44 cr |
|---|
| Net profit margin | 125.6% | 16.0% | 11.3% | 20.4% | 19.5% |
|---|
| Basic EPS | ₹113.71 | ₹19.45 | ₹10.94 | ₹16.85 | ₹20.33 |
|---|
| Diluted EPS | ₹113.71 | ₹19.45 | ₹10.94 | ₹16.85 | ₹20.33 |
|---|
HESTERBIO results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | -8.2% | — | — | — | — |
|---|
| Revenue QoQ | -22.8% | +29.3% | +9.1% | -15.6% | — |
|---|
| Operating profit YoY | -15.6% | — | — | — | — |
|---|
| Operating profit QoQ | -44.6% | +112.7% | +81.5% | -60.5% | — |
|---|
| Net profit YoY | +489.8% | — | — | — | — |
|---|
| Net profit QoQ | +506.8% | +82.3% | -39.3% | -12.1% | — |
|---|
| EPS YoY | +459.3% | — | — | — | — |
|---|
| EPS QoQ | +484.6% | +77.8% | -35.1% | -17.1% | — |
|---|
HESTERBIO annual results history
Full-year performance for HESTER BIOSCIENCES LTD, useful for reading each quarter in context.
HESTER BIOSCIENCES LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹333 cr | ₹311 cr | ₹305 cr | ₹266 cr |
|---|
| Total expenses | ₹255 cr | ₹266 cr | ₹262 cr | ₹225 cr |
|---|
| Gross profit | ₹238 cr | ₹208 cr | ₹194 cr | ₹180 cr |
|---|
| Operating profit (EBIT) | ₹77.13 cr | ₹45.24 cr | ₹42.28 cr | ₹41.57 cr |
|---|
| Operating margin | 23.2% | 14.5% | 13.9% | 15.6% |
|---|
| Interest cost | ₹7.42 cr | ₹8.34 cr | ₹9.12 cr | ₹5.15 cr |
|---|
| Profit before tax | ₹75.84 cr | ₹39.57 cr | ₹31.95 cr | ₹40.15 cr |
|---|
| Tax expense | ₹18.35 cr | ₹10.75 cr | ₹10.79 cr | ₹12.12 cr |
|---|
| Effective tax rate | 24.2% | 27.2% | 33.8% | 30.2% |
|---|
| Net profit (PAT) | ₹55.64 cr | ₹27.49 cr | ₹18.89 cr | ₹26.63 cr |
|---|
| Net profit margin | 16.7% | 8.8% | 6.2% | 10.0% |
|---|
| Basic EPS | ₹65.40 | ₹32.31 | ₹22.20 | ₹31.30 |
|---|
| Diluted EPS | ₹65.40 | ₹32.31 | ₹22.20 | ₹31.30 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹77.24 cr against ₹84.11 cr in Q1 FY26, and ₹100 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -22.8%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹61.51 cr, or 79.6% of revenue, with operating profit declined -15.6% year on year.
Margins, tax and profitability
Net profit of ₹96.98 cr works out to a net margin of 125.6% compared with 19.5% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, HESTER BIOSCIENCES LTD reported profit before tax of ₹16.33 cr, a tax charge of ₹4.95 cr (effective rate 30.3%), interest cost of ₹3.08 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹15.98 cr in Q4 FY26 to ₹96.98 cr in Q1 FY27, a change of +506.8%.
Trailing twelve months and annual context
Across the trailing four quarters HESTER BIOSCIENCES LTD has generated revenue of ₹326 cr and net profit of ₹136 cr, a trailing net margin of 41.8%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹333 cr with net profit of ₹55.64 cr and EPS of ₹65.40, versus the prior year where revenue grew +6.9% and profit grew +102.4%.
What to watch in the next HESTERBIO quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
HESTER BIOSCIENCES LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
HESTERBIO results coverage
No results report published for HESTERBIO yet — our desk covers each quarter within minutes of the filing.
HESTERBIO quarterly results FAQs
What were HESTER BIOSCIENCES LTD (HESTERBIO) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), HESTER BIOSCIENCES LTD reported revenue of ₹77.24 cr and net profit of ₹96.98 cr, a change of +489.8% year on year on -8.2% revenue growth. EPS stood at ₹113.71.
What is HESTERBIO profit margin in Q1 FY27?
HESTER BIOSCIENCES LTD posted a net profit margin of 125.6% and an operating margin of 20.4% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹326 cr and net profit ₹136 cr.
Did HESTERBIO results beat the previous quarter?
HESTER BIOSCIENCES LTD net profit changed +506.8% quarter on quarter, from ₹15.98 cr in Q4 FY26 to ₹96.98 cr in Q1 FY27.
When are HESTER BIOSCIENCES LTD (HESTERBIO) quarterly results?
HESTER BIOSCIENCES LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see HESTERBIO latest quarterly results?
Results coverage for HESTERBIO will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the HESTERBIO stock page.
What is HESTER BIOSCIENCES LTD annual revenue and profit?
For FY26, HESTER BIOSCIENCES LTD reported full-year revenue of ₹333 cr and net profit of ₹55.64 cr, with EPS of ₹65.40.
How many quarterly results has HESTERBIO declared recently?
Past results dates for HESTERBIO will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
